Anthos Logo Transparent.png
Anthos Therapeutics Announces Appointment of Bill Meury as CEO
22 avr. 2024 11h09 HE | Anthos Therapeutics
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Anthos Therapeutics, Inc. (Anthos), is a clinical-stage company developing innovative therapies for cardiovascular diseases, founded by...
Live image from pulsed-field ablation procedure
Irregular heartbeat can now be treated more safely and quicker than before
08 avr. 2024 12h52 HE | Nebraska Medicine
Omaha, Neb., April 08, 2024 (GLOBE NEWSWIRE) -- Nebraska Medicine patient Doris McCann found out something wasn't right with her heart when she got an Apple Watch for Christmas. "I started getting...
Transparency Market Research
Implantable Cardiac Monitor Market Predicted to Achieve 6.6% CAGR and Valued at USD 1.6 Billion by 2031- Report by Transparency Market Research, Inc.
18 mars 2024 10h30 HE | Transparency Market Research
Wilmington, Delaware, United States, March 18, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The implantable cardiac monitor industry was worth US$ 914.5 million in 2022. By the end of...
Emergen logo.png
Arrhythmia Monitoring Devices Market Size Worth USD 15.33 Billion in 2032 | Emergen Research
15 janv. 2024 07h33 HE | Emergen Research
Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global arrhythmia monitoring devices market size was USD 7.43 billion in 2022 and is expected to register a rapid revenue CAGR of 7.7% during the...
Global Atrial Fibrillation Market
Global $12.07 Bn Atrial Fibrillation Markets, 2017-2022, 2022-2027F, 2032F: Analysis, Forecasts and Competitive Landscape
26 oct. 2023 04h18 HE | Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation Global Market Report 2023" report has been added to's offering.The global atrial fibrillation market is...
Transparency Market Research
Anticoagulant Reversal Drugs Market Revenue to Cross USD 2.3 billion by 2031, Expanding at a CAGR of 11.3% - Exclusive Report by Transparency Market Research
17 oct. 2023 03h40 HE | Transparency Market Research
Wilmington, Delaware, United States, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global anticoagulant reversal drugs market is projected to flourish at a CAGR of 11.3%...
ZyVersa Therapeutics Announces Research Published in The Journal of Clinical Investigation Reinforcing IC 100’s Rationale for Inhibiting ASC Specks to Attenuate Spread of Inflammation into Surrounding Tissues
22 sept. 2023 06h35 HE | ZyVersa Therapeutics
Patients with chronic kidney disease (“CKD”) exhibit chronic systemic inflammation characterized by increased circulating levels of IL-1β, IL-6, and CRP.This study demonstrated that CKD-induced IL-1β...
AMR Logo.png
Clot Busting Drugs Market to Reach $60 Billion, Globally, by 2032 at 8.2% CAGR: Allied Market Research
24 juil. 2023 09h55 HE | Allied Market Research
Portland,OR, July 24, 2023 (GLOBE NEWSWIRE) -- Allied Market Research has recently published a report, titled, “Clot Busting Drugs Market by Product (Thrombolytic Drugs, Anti-Platelet Drugs,...
Anthos Logo Transparent.png
Anthos Therapeutics Supported Global Survey of 3000+ Patients Prescribed Anticoagulants Detailing Impact of Patient-Relevant Bleeding (PRB) Presented at ISTH 2023
26 juin 2023 07h00 HE | Anthos Therapeutics
Patient-Centric Survey Conducted in Collaborationwith and the National Blood Clot Alliance Findings Suggest “Patient-Relevant Bleeding” More Accurate Than Current Terminology,...
Anthos Logo Transparent.png
Regulatory Authorities in China and Japan Approve Clinical Trials for Anthos Therapeutics’ Dual-Acting Factor XI/XIa Inhibitor Abelacimab
08 juin 2023 11h10 HE | Anthos Therapeutics
Fewer than 26% of Chinese Patients with Atrial Fibrillation are Prescribed an Anticoagulant, while in Japan Almost One-Third of Patients are Undertreated Approximately 63% of Cancer Patients in China...